Hypermethylation of multiple genes in pancreatic adenocarcinoma - PubMed (original) (raw)
. 2000 Apr 1;60(7):1835-9.
Affiliations
- PMID: 10766168
Hypermethylation of multiple genes in pancreatic adenocarcinoma
T Ueki et al. Cancer Res. 2000.
Abstract
Hypermethylation of CpG islands is a common mechanism by which tumor suppressor genes are inactivated. We studied 45 pancreatic carcinomas and 14 normal pancreata for aberrant DNA methylation of CpG islands of multiple genes and clones using methylation-specific PCR (MSP) and bisulfite-modified sequencing. Using MSP, we detected aberrant methylation of at least one locus in 60% of carcinomas. The genes analyzed included RARbeta (methylated in 20%), p16 (18%), CACNA1G (16%), TIMP-3 (11%), E-cad (7%), THBS1 (7%), hMLH1 (4%), DAP kinase (2%), and MGMT (0%). In addition, aberrant methylation was found in three CpG islands (MINT31, -1, and -2) in 38, 38, and 14% of carcinomas, respectively. Hypermethylation was largely confined to the carcinomas with only three loci (E-cad, DAP kinase, and MINT2) harboring methylation in some normal pancreata (36, 21, and 14%, respectively). Simultaneous methylation of at least four loci was observed in 5 of 36 (14%) pancreatic adenocarcinomas. We defined this subgroup of pancreatic adenocarcinomas as "CpG island-methylator-phenotype positive (CIMP+)." Two of four carcinomas with microsatellite instability harbored promoter hypermethylation of hMLH1, and both cases were CIMP+. Thus, we conclude that many pancreatic carcinomas hypermethylate a small percentage of genes, whereas a subset displays a CIMP+ phenotype.
Similar articles
- Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Ueki T, Walter KM, Skinner H, Jaffee E, Hruban RH, Goggins M. Ueki T, et al. Oncogene. 2002 Mar 27;21(13):2114-7. doi: 10.1038/sj.onc.1205275. Oncogene. 2002. PMID: 11960385 - Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Zöchbauer-Müller S, et al. Cancer Res. 2001 Jan 1;61(1):249-55. Cancer Res. 2001. PMID: 11196170 - CpG island methylation in carcinoid and pancreatic endocrine tumors.
Chan AO, Kim SG, Bedeir A, Issa JP, Hamilton SR, Rashid A. Chan AO, et al. Oncogene. 2003 Feb 13;22(6):924-34. doi: 10.1038/sj.onc.1206123. Oncogene. 2003. PMID: 12584572 - DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature Review.
Henriksen SD, Madsen PH, Krarup H, Thorlacius-Ussing O. Henriksen SD, et al. Pancreas. 2015 Oct;44(7):1036-45. doi: 10.1097/MPA.0000000000000487. Pancreas. 2015. PMID: 26355546 Review.
Cited by
- A non-mutated TROP2 fingerprint in cancer genetics.
Guerra E, Di Pietro R, Stati G, Alberti S. Guerra E, et al. Front Oncol. 2023 Jun 29;13:1151090. doi: 10.3389/fonc.2023.1151090. eCollection 2023. Front Oncol. 2023. PMID: 37456256 Free PMC article. - HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation.
Chia L, Wang B, Kim JH, Luo LZ, Shuai S, Herrera I, Chen SY, Li L, Xian L, Huso T, Heydarian M, Reddy K, Sung WJ, Ishiyama S, Guo G, Jaffee E, Zheng L, Cope LM, Gabrielson K, Wood L, Resar L. Chia L, et al. J Clin Invest. 2023 Mar 15;133(6):e151601. doi: 10.1172/JCI151601. J Clin Invest. 2023. PMID: 36919699 Free PMC article. - Variabilities in global DNA methylation and β-sheet richness establish spectroscopic landscapes among subtypes of pancreatic cancer.
Szymoński K, Lipiec E, Sofińska K, Skirlińska-Nosek K, Czaja M, Seweryn S, Wilkosz N, Birarda G, Piccirilli F, Vaccari L, Chmura Ł, Szpor J, Adamek D, Szymoński M. Szymoński K, et al. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1792-1810. doi: 10.1007/s00259-023-06121-7. Epub 2023 Feb 9. Eur J Nucl Med Mol Imaging. 2023. PMID: 36757432 Free PMC article. - Senescence-Associated miRNAs and Their Role in Pancreatic Cancer.
Popov A, Mandys V. Popov A, et al. Pathol Oncol Res. 2022 Apr 29;28:1610156. doi: 10.3389/pore.2022.1610156. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35570840 Free PMC article. Review. - Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis.
Yates J, Boeva V. Yates J, et al. Brief Bioinform. 2022 Mar 10;23(2):bbab610. doi: 10.1093/bib/bbab610. Brief Bioinform. 2022. PMID: 35134107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous